| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthopedics | 24 | 2018 | 904 | 2.550 |
Why?
|
| Dermatologic Agents | 8 | 2015 | 278 | 1.690 |
Why?
|
| Skin Aging | 4 | 2016 | 127 | 1.450 |
Why?
|
| Forearm | 10 | 2009 | 409 | 1.070 |
Why?
|
| Tendon Injuries | 10 | 2012 | 313 | 1.000 |
Why?
|
| Hyperpigmentation | 3 | 2016 | 112 | 0.990 |
Why?
|
| Medical Errors | 11 | 2015 | 1297 | 0.940 |
Why?
|
| Tendons | 9 | 2012 | 548 | 0.770 |
Why?
|
| Arthroplasty | 7 | 2001 | 305 | 0.760 |
Why?
|
| Orthopedic Procedures | 8 | 2015 | 1288 | 0.720 |
Why?
|
| Acne Vulgaris | 6 | 2015 | 302 | 0.650 |
Why?
|
| Naphthalenes | 4 | 2012 | 194 | 0.610 |
Why?
|
| Prostaglandin Antagonists | 2 | 2013 | 30 | 0.570 |
Why?
|
| Hydroquinones | 2 | 2013 | 36 | 0.560 |
Why?
|
| Skin Care | 1 | 2016 | 49 | 0.550 |
Why?
|
| Chlorophyllides | 1 | 2015 | 53 | 0.530 |
Why?
|
| Vitamin A | 2 | 2016 | 615 | 0.520 |
Why?
|
| Hand Injuries | 7 | 2012 | 242 | 0.520 |
Why?
|
| Metacarpophalangeal Joint | 6 | 2005 | 82 | 0.500 |
Why?
|
| Elbow Joint | 4 | 2009 | 357 | 0.480 |
Why?
|
| Leadership | 4 | 2018 | 1357 | 0.480 |
Why?
|
| Osteoarthritis, Knee | 3 | 2009 | 1222 | 0.470 |
Why?
|
| Administration, Cutaneous | 7 | 2016 | 711 | 0.470 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2007 | 306 | 0.450 |
Why?
|
| Sialoglycoproteins | 5 | 2005 | 318 | 0.450 |
Why?
|
| Journal Impact Factor | 1 | 2014 | 156 | 0.440 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 651 | 0.430 |
Why?
|
| Finger Injuries | 7 | 2014 | 139 | 0.410 |
Why?
|
| Dinoprostone | 3 | 2013 | 600 | 0.390 |
Why?
|
| Cosmetic Techniques | 1 | 2012 | 135 | 0.360 |
Why?
|
| Thumb | 7 | 2001 | 227 | 0.350 |
Why?
|
| Ligaments | 4 | 2008 | 128 | 0.350 |
Why?
|
| Quality of Health Care | 4 | 2013 | 4371 | 0.350 |
Why?
|
| Education, Medical, Graduate | 4 | 2018 | 2291 | 0.340 |
Why?
|
| Ethics, Medical | 2 | 2013 | 792 | 0.330 |
Why?
|
| Safety | 3 | 2011 | 1186 | 0.330 |
Why?
|
| Ligaments, Articular | 2 | 2001 | 298 | 0.320 |
Why?
|
| Internship and Residency | 6 | 2014 | 5788 | 0.320 |
Why?
|
| Hip Fractures | 4 | 2012 | 955 | 0.310 |
Why?
|
| Radius Fractures | 3 | 2002 | 501 | 0.310 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.310 |
Why?
|
| Carpal Bones | 5 | 2000 | 77 | 0.310 |
Why?
|
| Communication | 4 | 2015 | 3749 | 0.300 |
Why?
|
| Educational Measurement | 1 | 2014 | 1210 | 0.300 |
Why?
|
| Specialty Boards | 1 | 2009 | 227 | 0.300 |
Why?
|
| Malpractice | 1 | 2012 | 572 | 0.300 |
Why?
|
| Muscle, Skeletal | 4 | 2008 | 4931 | 0.300 |
Why?
|
| Employee Discipline | 1 | 2006 | 8 | 0.290 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3843 | 0.290 |
Why?
|
| Musculoskeletal Diseases | 4 | 2012 | 581 | 0.290 |
Why?
|
| Accreditation | 1 | 2009 | 450 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 10 | 2005 | 3712 | 0.280 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2006 | 30 | 0.270 |
Why?
|
| Joint Prosthesis | 6 | 1998 | 258 | 0.270 |
Why?
|
| Wrist Injuries | 4 | 2003 | 208 | 0.260 |
Why?
|
| Face | 4 | 2015 | 994 | 0.260 |
Why?
|
| Nerve Compression Syndromes | 2 | 1998 | 160 | 0.260 |
Why?
|
| Forecasting | 4 | 2009 | 2951 | 0.260 |
Why?
|
| Laser Therapy | 1 | 2012 | 1072 | 0.250 |
Why?
|
| Finger Joint | 5 | 2014 | 108 | 0.250 |
Why?
|
| Safety Management | 2 | 2009 | 783 | 0.250 |
Why?
|
| Radius | 6 | 2009 | 422 | 0.250 |
Why?
|
| Technology, High-Cost | 1 | 2004 | 32 | 0.250 |
Why?
|
| Biomedical Technology | 1 | 2007 | 220 | 0.250 |
Why?
|
| Humans | 159 | 2018 | 744343 | 0.240 |
Why?
|
| Ulna | 6 | 2009 | 133 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 3923 | 0.230 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 1432 | 0.230 |
Why?
|
| Osteoarthritis | 5 | 2005 | 1036 | 0.220 |
Why?
|
| Physician's Role | 2 | 2015 | 943 | 0.220 |
Why?
|
| Running | 1 | 2007 | 480 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3610 | 0.210 |
Why?
|
| Hockey | 1 | 2003 | 90 | 0.210 |
Why?
|
| Tomography, Emission-Computed | 3 | 2000 | 1144 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2012 | 1458 | 0.200 |
Why?
|
| Prostheses and Implants | 4 | 2001 | 1387 | 0.200 |
Why?
|
| Fractures, Bone | 8 | 2000 | 1947 | 0.200 |
Why?
|
| Cartilage, Articular | 2 | 2007 | 1095 | 0.190 |
Why?
|
| Knee Joint | 3 | 2007 | 1680 | 0.190 |
Why?
|
| Arm | 5 | 2014 | 589 | 0.190 |
Why?
|
| Range of Motion, Articular | 7 | 2009 | 1578 | 0.190 |
Why?
|
| Wrist Joint | 3 | 2000 | 256 | 0.180 |
Why?
|
| Arthritis | 3 | 2001 | 659 | 0.180 |
Why?
|
| Medicare | 5 | 2012 | 6566 | 0.180 |
Why?
|
| Adult | 63 | 2018 | 214055 | 0.180 |
Why?
|
| Specialization | 1 | 2004 | 777 | 0.170 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2000 | 262 | 0.170 |
Why?
|
| Tendon Transfer | 2 | 2000 | 122 | 0.170 |
Why?
|
| Practice Management, Medical | 1 | 2001 | 196 | 0.170 |
Why?
|
| Femoral Vein | 3 | 1998 | 159 | 0.170 |
Why?
|
| United States | 23 | 2018 | 69872 | 0.160 |
Why?
|
| Quality Assurance, Health Care | 4 | 2009 | 2212 | 0.160 |
Why?
|
| Female | 73 | 2018 | 380194 | 0.160 |
Why?
|
| Gels | 3 | 2015 | 427 | 0.160 |
Why?
|
| Middle Aged | 54 | 2018 | 213383 | 0.160 |
Why?
|
| Aged | 47 | 2018 | 163280 | 0.150 |
Why?
|
| Physician Executives | 1 | 2018 | 128 | 0.150 |
Why?
|
| Fellowships and Scholarships | 2 | 2012 | 1076 | 0.150 |
Why?
|
| Hand | 4 | 2014 | 884 | 0.150 |
Why?
|
| Male | 81 | 2015 | 350118 | 0.150 |
Why?
|
| Cadaver | 5 | 2001 | 1337 | 0.150 |
Why?
|
| Exercise | 2 | 2018 | 5615 | 0.150 |
Why?
|
| Lunate Bone | 1 | 1997 | 36 | 0.150 |
Why?
|
| Embolism, Fat | 7 | 1976 | 47 | 0.140 |
Why?
|
| Menopause | 1 | 2004 | 1626 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 2 | 2010 | 1876 | 0.140 |
Why?
|
| Radiography | 12 | 2012 | 7023 | 0.140 |
Why?
|
| Academies and Institutes | 1 | 2018 | 317 | 0.140 |
Why?
|
| Administration, Topical | 4 | 2015 | 690 | 0.140 |
Why?
|
| Clinical Protocols | 3 | 2012 | 1462 | 0.130 |
Why?
|
| Pronation | 2 | 2009 | 51 | 0.130 |
Why?
|
| Pruritus | 2 | 2016 | 361 | 0.130 |
Why?
|
| Supination | 2 | 2009 | 68 | 0.130 |
Why?
|
| Patient Readmission | 4 | 2015 | 3114 | 0.130 |
Why?
|
| Fees and Charges | 1 | 2016 | 195 | 0.130 |
Why?
|
| Fracture Fixation, Internal | 3 | 2000 | 917 | 0.130 |
Why?
|
| Patient Satisfaction | 5 | 2014 | 3396 | 0.130 |
Why?
|
| Leg Injuries | 6 | 1978 | 178 | 0.130 |
Why?
|
| Drug Compounding | 1 | 2016 | 242 | 0.130 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 607 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2000 | 2016 | 0.120 |
Why?
|
| Skin Physiological Phenomena | 1 | 2015 | 180 | 0.120 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1995 | 83 | 0.120 |
Why?
|
| Emollients | 1 | 2014 | 34 | 0.120 |
Why?
|
| Median Nerve | 1 | 1995 | 129 | 0.120 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 5 | 2005 | 297 | 0.120 |
Why?
|
| Length of Stay | 4 | 2012 | 6309 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 3229 | 0.120 |
Why?
|
| Treatment Outcome | 20 | 2018 | 63114 | 0.120 |
Why?
|
| Skin Pigmentation | 2 | 2015 | 282 | 0.120 |
Why?
|
| Photosensitivity Disorders | 2 | 2013 | 78 | 0.120 |
Why?
|
| Sunlight | 2 | 2013 | 325 | 0.120 |
Why?
|
| Amputation, Traumatic | 5 | 2000 | 123 | 0.120 |
Why?
|
| Esthetics | 1 | 2015 | 306 | 0.120 |
Why?
|
| Sprains and Strains | 1 | 2014 | 78 | 0.120 |
Why?
|
| Internal Fixators | 1 | 1994 | 188 | 0.110 |
Why?
|
| Erythema | 2 | 2014 | 257 | 0.110 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2001 | 941 | 0.110 |
Why?
|
| Osteoporosis | 2 | 2005 | 1580 | 0.110 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 2759 | 0.110 |
Why?
|
| Tensile Strength | 3 | 2001 | 335 | 0.110 |
Why?
|
| Methods | 8 | 1997 | 1129 | 0.110 |
Why?
|
| Hip Joint | 3 | 2012 | 1002 | 0.110 |
Why?
|
| Benzoyl Peroxide | 1 | 2012 | 18 | 0.110 |
Why?
|
| Fingers | 5 | 1996 | 513 | 0.110 |
Why?
|
| Exercise Therapy | 2 | 2018 | 906 | 0.110 |
Why?
|
| Joint Diseases | 2 | 2011 | 480 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2005 | 5221 | 0.110 |
Why?
|
| Hemophilia A | 1 | 1995 | 351 | 0.110 |
Why?
|
| Thrombophlebitis | 2 | 1990 | 309 | 0.110 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 5319 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 1998 | 1301 | 0.100 |
Why?
|
| Surgical Wound Infection | 3 | 1998 | 1540 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 657 | 0.100 |
Why?
|
| Disability Evaluation | 3 | 2014 | 1827 | 0.100 |
Why?
|
| Postoperative Complications | 7 | 2015 | 15295 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 1997 | 969 | 0.100 |
Why?
|
| Editorial Policies | 1 | 2016 | 451 | 0.100 |
Why?
|
| Single-Blind Method | 2 | 2013 | 1590 | 0.100 |
Why?
|
| Eczema | 1 | 2014 | 231 | 0.100 |
Why?
|
| Physician Impairment | 1 | 2012 | 73 | 0.100 |
Why?
|
| Saphenous Vein | 1 | 1995 | 532 | 0.100 |
Why?
|
| Suntan | 1 | 2011 | 17 | 0.100 |
Why?
|
| Health Care Costs | 4 | 2011 | 3209 | 0.100 |
Why?
|
| Ultrasonography | 4 | 2012 | 5985 | 0.100 |
Why?
|
| Arylsulfatases | 1 | 1990 | 11 | 0.100 |
Why?
|
| Rejuvenation | 1 | 2012 | 91 | 0.100 |
Why?
|
| Societies, Medical | 5 | 2018 | 3743 | 0.100 |
Why?
|
| Sunburn | 2 | 2011 | 155 | 0.100 |
Why?
|
| Dermatitis, Atopic | 2 | 2014 | 654 | 0.100 |
Why?
|
| Compartment Syndromes | 2 | 1995 | 153 | 0.100 |
Why?
|
| Osteotomy | 3 | 2000 | 822 | 0.100 |
Why?
|
| Genetic Vectors | 3 | 2000 | 3420 | 0.090 |
Why?
|
| Rupture | 3 | 2003 | 433 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2012 | 1462 | 0.090 |
Why?
|
| Metatarsus | 1 | 1990 | 19 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2373 | 0.090 |
Why?
|
| Gene Transfer Techniques | 6 | 2005 | 1224 | 0.090 |
Why?
|
| Movement | 3 | 1990 | 1471 | 0.090 |
Why?
|
| Trigger Finger Disorder | 1 | 2010 | 52 | 0.090 |
Why?
|
| Catheterization | 2 | 1995 | 1470 | 0.090 |
Why?
|
| Sunscreening Agents | 1 | 2011 | 132 | 0.090 |
Why?
|
| Femoral Fractures | 2 | 1990 | 376 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2018 | 1181 | 0.090 |
Why?
|
| Hip Prosthesis | 4 | 2012 | 917 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 1995 | 538 | 0.090 |
Why?
|
| Bone Diseases | 3 | 2000 | 416 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1995 | 2559 | 0.090 |
Why?
|
| Health Care Surveys | 3 | 2012 | 2453 | 0.090 |
Why?
|
| Hallux Valgus | 1 | 1990 | 65 | 0.090 |
Why?
|
| Patient Care Team | 3 | 2015 | 2531 | 0.090 |
Why?
|
| Wound Healing | 4 | 2012 | 2785 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 1999 | 1339 | 0.080 |
Why?
|
| Publishing | 1 | 2016 | 833 | 0.080 |
Why?
|
| Prosthesis Failure | 4 | 2005 | 1206 | 0.080 |
Why?
|
| Spinal Cord Compression | 2 | 1986 | 235 | 0.080 |
Why?
|
| Fibrinolysis | 1 | 1990 | 322 | 0.080 |
Why?
|
| Lung Neoplasms | 8 | 2005 | 13102 | 0.080 |
Why?
|
| Physicians | 1 | 2006 | 4567 | 0.080 |
Why?
|
| Antioxidants | 2 | 2013 | 1663 | 0.080 |
Why?
|
| Adolescent | 26 | 2015 | 85781 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2012 | 2618 | 0.080 |
Why?
|
| Cartilage Diseases | 1 | 2009 | 160 | 0.080 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2010 | 300 | 0.080 |
Why?
|
| Hemiplegia | 1 | 1988 | 135 | 0.080 |
Why?
|
| Epidermis | 1 | 1990 | 528 | 0.080 |
Why?
|
| Video Recording | 1 | 2012 | 949 | 0.070 |
Why?
|
| Kyphosis | 2 | 1986 | 237 | 0.070 |
Why?
|
| Casts, Surgical | 3 | 2000 | 178 | 0.070 |
Why?
|
| Follow-Up Studies | 7 | 2013 | 39050 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 1060 | 0.070 |
Why?
|
| National Practitioner Data Bank | 1 | 2006 | 13 | 0.070 |
Why?
|
| Hospital Administration | 1 | 1991 | 353 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 10943 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1995 | 2232 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6489 | 0.070 |
Why?
|
| Governing Board | 1 | 2006 | 53 | 0.070 |
Why?
|
| Aged, 80 and over | 14 | 2014 | 57776 | 0.070 |
Why?
|
| Equipment Safety | 1 | 2007 | 264 | 0.070 |
Why?
|
| Professional Misconduct | 1 | 2006 | 73 | 0.070 |
Why?
|
| Dissection | 1 | 2008 | 295 | 0.070 |
Why?
|
| Managed Care Programs | 2 | 2002 | 950 | 0.070 |
Why?
|
| Fracture Healing | 2 | 2000 | 427 | 0.070 |
Why?
|
| Licensure | 1 | 2006 | 124 | 0.070 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12026 | 0.070 |
Why?
|
| Physician Incentive Plans | 1 | 2007 | 161 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2007 | 262 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2015 | 4687 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1995 | 1363 | 0.070 |
Why?
|
| Transplantation, Autologous | 6 | 2005 | 2124 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15540 | 0.060 |
Why?
|
| Time Factors | 10 | 2014 | 40075 | 0.060 |
Why?
|
| Hand Strength | 3 | 2000 | 448 | 0.060 |
Why?
|
| Synovial Fluid | 2 | 2005 | 394 | 0.060 |
Why?
|
| Quality of Life | 4 | 2018 | 12804 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2005 | 2050 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1547 | 0.060 |
Why?
|
| Shoulder Joint | 1 | 2011 | 695 | 0.060 |
Why?
|
| Pelvic Bones | 2 | 1978 | 265 | 0.060 |
Why?
|
| Fatigue | 1 | 2012 | 1531 | 0.060 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2007 | 264 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2012 | 2708 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2012 | 1062 | 0.060 |
Why?
|
| Knee Prosthesis | 2 | 1995 | 425 | 0.060 |
Why?
|
| Knee Injuries | 1 | 2009 | 490 | 0.060 |
Why?
|
| Titanium | 2 | 2005 | 494 | 0.060 |
Why?
|
| Adaptation, Psychological | 5 | 2014 | 2576 | 0.060 |
Why?
|
| Joints | 1 | 2006 | 326 | 0.060 |
Why?
|
| Skin | 2 | 2015 | 4364 | 0.060 |
Why?
|
| Joint Instability | 3 | 2001 | 792 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2005 | 11524 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2282 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2012 | 1471 | 0.060 |
Why?
|
| Reference Values | 2 | 2009 | 4982 | 0.060 |
Why?
|
| Equipment Design | 1 | 2012 | 3582 | 0.060 |
Why?
|
| Bone and Bones | 1 | 1994 | 2575 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 469 | 0.060 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2003 | 93 | 0.060 |
Why?
|
| Pinealoma | 1 | 2003 | 54 | 0.060 |
Why?
|
| Military Medicine | 3 | 1973 | 176 | 0.050 |
Why?
|
| Bone Neoplasms | 4 | 1988 | 2529 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 914 | 0.050 |
Why?
|
| Young Adult | 8 | 2018 | 56430 | 0.050 |
Why?
|
| Incidence | 5 | 2012 | 20947 | 0.050 |
Why?
|
| Pineal Gland | 1 | 2003 | 166 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 913 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2015 | 8324 | 0.050 |
Why?
|
| Silicone Elastomers | 3 | 1990 | 84 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 1009 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2011 | 1859 | 0.050 |
Why?
|
| Cisplatin | 5 | 2005 | 1662 | 0.050 |
Why?
|
| Tibia | 1 | 2007 | 1077 | 0.050 |
Why?
|
| Nerve Block | 1 | 1988 | 644 | 0.050 |
Why?
|
| Retrospective Studies | 13 | 2012 | 77449 | 0.050 |
Why?
|
| Arm Injuries | 2 | 1973 | 160 | 0.050 |
Why?
|
| Injections, Intra-Articular | 2 | 2000 | 278 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1950 | 0.050 |
Why?
|
| Wrist | 4 | 1985 | 224 | 0.050 |
Why?
|
| Risk Factors | 7 | 2015 | 72290 | 0.050 |
Why?
|
| Methylmethacrylates | 1 | 1980 | 72 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2005 | 540 | 0.050 |
Why?
|
| Amputation Stumps | 3 | 1976 | 39 | 0.050 |
Why?
|
| Vinblastine | 3 | 1999 | 502 | 0.050 |
Why?
|
| Documentation | 1 | 2006 | 871 | 0.050 |
Why?
|
| Office Visits | 2 | 2001 | 598 | 0.050 |
Why?
|
| Myositis Ossificans | 2 | 2005 | 79 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1198 | 0.040 |
Why?
|
| Combined Modality Therapy | 6 | 2005 | 8642 | 0.040 |
Why?
|
| Interprofessional Relations | 2 | 2004 | 1011 | 0.040 |
Why?
|
| Survival Rate | 7 | 2005 | 12788 | 0.040 |
Why?
|
| Drug Combinations | 3 | 2012 | 1959 | 0.040 |
Why?
|
| Spine | 1 | 2007 | 1144 | 0.040 |
Why?
|
| Fractures, Malunited | 1 | 2000 | 82 | 0.040 |
Why?
|
| Decision Making | 1 | 2014 | 3887 | 0.040 |
Why?
|
| Feasibility Studies | 3 | 2018 | 5078 | 0.040 |
Why?
|
| Membranes | 2 | 1996 | 173 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 1999 | 358 | 0.040 |
Why?
|
| Leg | 3 | 2013 | 1116 | 0.040 |
Why?
|
| Radiotherapy | 1 | 1986 | 1533 | 0.040 |
Why?
|
| Medication Errors | 1 | 2005 | 798 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2001 | 1686 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2009 | 35421 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2012 | 5317 | 0.040 |
Why?
|
| Bone Cysts | 1 | 1979 | 47 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 1584 | 0.040 |
Why?
|
| Reoperation | 3 | 2015 | 4201 | 0.040 |
Why?
|
| Athletic Injuries | 2 | 1987 | 1154 | 0.040 |
Why?
|
| Acute Disease | 3 | 2000 | 7149 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 6622 | 0.040 |
Why?
|
| Prevalence | 2 | 2009 | 15226 | 0.040 |
Why?
|
| Fractures, Ununited | 1 | 2000 | 165 | 0.040 |
Why?
|
| Blood Substitutes | 1 | 1998 | 58 | 0.040 |
Why?
|
| Cementation | 1 | 1998 | 91 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 1071 | 0.040 |
Why?
|
| Otolaryngology | 1 | 2005 | 645 | 0.040 |
Why?
|
| Rabbits | 2 | 1999 | 4894 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2011 | 5391 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1980 | 528 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1998 | 134 | 0.040 |
Why?
|
| Ulnar Nerve | 1 | 1998 | 106 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2012 | 3047 | 0.040 |
Why?
|
| Sex Factors | 2 | 2009 | 10397 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 2 | 1978 | 146 | 0.040 |
Why?
|
| Rosacea | 1 | 1998 | 49 | 0.040 |
Why?
|
| Arthroplasty, Replacement | 2 | 2000 | 339 | 0.040 |
Why?
|
| Skin Abnormalities | 1 | 1978 | 60 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 1998 | 354 | 0.040 |
Why?
|
| Women's Health | 1 | 2007 | 2034 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 4042 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2001 | 510 | 0.040 |
Why?
|
| Cross Infection | 1 | 2007 | 1416 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 20822 | 0.040 |
Why?
|
| Desonide | 1 | 1997 | 1 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.040 |
Why?
|
| Microsurgery | 1 | 1983 | 796 | 0.040 |
Why?
|
| Recurrence | 4 | 1998 | 8340 | 0.040 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1997 | 87 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2765 | 0.040 |
Why?
|
| Pain | 5 | 2014 | 4986 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2001 | 411 | 0.040 |
Why?
|
| Risk Assessment | 5 | 2015 | 23338 | 0.040 |
Why?
|
| Comorbidity | 1 | 2012 | 10388 | 0.040 |
Why?
|
| Metronidazole | 1 | 1998 | 217 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2001 | 14722 | 0.040 |
Why?
|
| Humerus | 1 | 1998 | 266 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 1736 | 0.040 |
Why?
|
| Arthroscopy | 1 | 2003 | 926 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 1997 | 337 | 0.040 |
Why?
|
| Age Factors | 4 | 2012 | 18370 | 0.030 |
Why?
|
| Pressure | 3 | 1995 | 1203 | 0.030 |
Why?
|
| Lipids | 3 | 2014 | 3305 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 2 | 1990 | 252 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2008 | 6196 | 0.030 |
Why?
|
| Splints | 2 | 1988 | 111 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1999 | 507 | 0.030 |
Why?
|
| Prognosis | 4 | 2012 | 29063 | 0.030 |
Why?
|
| Lung | 2 | 1990 | 9856 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2005 | 4161 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1998 | 420 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 1998 | 354 | 0.030 |
Why?
|
| Accidents, Aviation | 1 | 2015 | 14 | 0.030 |
Why?
|
| Carboplatin | 1 | 1999 | 801 | 0.030 |
Why?
|
| Braces | 2 | 1993 | 135 | 0.030 |
Why?
|
| Androgens | 1 | 1983 | 1281 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1996 | 1263 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 1998 | 413 | 0.030 |
Why?
|
| Arthrography | 2 | 2000 | 149 | 0.030 |
Why?
|
| Professional Competence | 1 | 2018 | 447 | 0.030 |
Why?
|
| Aviation | 1 | 2015 | 42 | 0.030 |
Why?
|
| Efficiency | 1 | 2018 | 462 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2416 | 0.030 |
Why?
|
| Postoperative Care | 2 | 1998 | 1486 | 0.030 |
Why?
|
| Neuroma | 1 | 1976 | 103 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1998 | 687 | 0.030 |
Why?
|
| Fascia | 1 | 1995 | 135 | 0.030 |
Why?
|
| Osteoma, Osteoid | 1 | 1974 | 80 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 1869 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 1620 | 0.030 |
Why?
|
| Osteomyelitis | 2 | 1995 | 402 | 0.030 |
Why?
|
| Orthopedic Equipment | 1 | 1973 | 22 | 0.030 |
Why?
|
| Erythropoietin | 1 | 1998 | 726 | 0.030 |
Why?
|
| Lumbar Vertebrae | 3 | 1986 | 1848 | 0.030 |
Why?
|
| Heel | 1 | 1974 | 36 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 1997 | 442 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 1996 | 515 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 12072 | 0.030 |
Why?
|
| Occlusive Dressings | 1 | 1973 | 50 | 0.030 |
Why?
|
| Shoulder | 2 | 1988 | 299 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1998 | 748 | 0.030 |
Why?
|
| Dogs | 2 | 1995 | 3912 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1997 | 553 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2000 | 2375 | 0.030 |
Why?
|
| Protective Devices | 1 | 1974 | 71 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 1998 | 452 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1997 | 1790 | 0.030 |
Why?
|
| Elasticity | 1 | 1995 | 657 | 0.030 |
Why?
|
| Linear Models | 2 | 2012 | 5952 | 0.030 |
Why?
|
| Acrylic Resins | 1 | 1973 | 142 | 0.030 |
Why?
|
| Hospitalization | 2 | 2012 | 10262 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2005 | 11031 | 0.030 |
Why?
|
| Hip | 1 | 1974 | 257 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1681 | 0.030 |
Why?
|
| Impulsive Behavior | 1 | 2015 | 316 | 0.030 |
Why?
|
| Animals | 11 | 2000 | 168757 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 281 | 0.030 |
Why?
|
| Bibliometrics | 1 | 2016 | 339 | 0.030 |
Why?
|
| Shoulder Pain | 1 | 2014 | 144 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1997 | 703 | 0.030 |
Why?
|
| External Fixators | 1 | 1993 | 94 | 0.030 |
Why?
|
| Cyclophosphamide | 3 | 2005 | 2242 | 0.030 |
Why?
|
| Cicatrix | 1 | 1998 | 764 | 0.030 |
Why?
|
| General Surgery | 2 | 2012 | 1636 | 0.030 |
Why?
|
| Diterpenes | 1 | 2013 | 173 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 1999 | 592 | 0.030 |
Why?
|
| Macrophages | 2 | 2005 | 5655 | 0.030 |
Why?
|
| Rhabdomyosarcoma | 1 | 1995 | 382 | 0.030 |
Why?
|
| Heart Failure | 3 | 2012 | 10900 | 0.030 |
Why?
|
| Mycobacterium Infections | 1 | 1972 | 119 | 0.030 |
Why?
|
| Phlebography | 2 | 1990 | 333 | 0.030 |
Why?
|
| Carmustine | 2 | 2005 | 137 | 0.030 |
Why?
|
| Data Collection | 1 | 2001 | 3341 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 1995 | 367 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 281 | 0.030 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2011 | 33 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 1998 | 2110 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 4776 | 0.020 |
Why?
|
| Solar System | 1 | 2011 | 12 | 0.020 |
Why?
|
| Skin Transplantation | 2 | 1974 | 1074 | 0.020 |
Why?
|
| Color | 1 | 2012 | 307 | 0.020 |
Why?
|
| Bone Nails | 1 | 1993 | 219 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1997 | 740 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11366 | 0.020 |
Why?
|
| Thoracic Vertebrae | 2 | 1986 | 608 | 0.020 |
Why?
|
| Locomotion | 1 | 1973 | 378 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2009 | 20129 | 0.020 |
Why?
|
| Steryl-Sulfatase | 1 | 1990 | 11 | 0.020 |
Why?
|
| Lasers | 1 | 1995 | 952 | 0.020 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2011 | 131 | 0.020 |
Why?
|
| Thorax | 2 | 2013 | 547 | 0.020 |
Why?
|
| Alloys | 2 | 2005 | 122 | 0.020 |
Why?
|
| Walking | 1 | 1998 | 1180 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2011 | 92 | 0.020 |
Why?
|
| Action Potentials | 1 | 1998 | 1806 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1995 | 477 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1978 | 1416 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2001 | 2400 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2000 | 18029 | 0.020 |
Why?
|
| Shoulder Fractures | 1 | 2011 | 88 | 0.020 |
Why?
|
| Catastrophization | 1 | 2014 | 316 | 0.020 |
Why?
|
| Chondroma | 1 | 1970 | 58 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1995 | 639 | 0.020 |
Why?
|
| Plasminogen Inactivators | 1 | 1990 | 38 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2012 | 623 | 0.020 |
Why?
|
| Refsum Disease | 1 | 1969 | 8 | 0.020 |
Why?
|
| Shoulder Dislocation | 1 | 2011 | 122 | 0.020 |
Why?
|
| Product Labeling | 1 | 2011 | 79 | 0.020 |
Why?
|
| Tritium | 1 | 1990 | 745 | 0.020 |
Why?
|
| Wound Infection | 1 | 1972 | 242 | 0.020 |
Why?
|
| Femur Head | 1 | 1972 | 301 | 0.020 |
Why?
|
| Aneurysm | 1 | 1973 | 339 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1973 | 315 | 0.020 |
Why?
|
| Employment | 1 | 1997 | 1132 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1976 | 1127 | 0.020 |
Why?
|
| Suture Techniques | 1 | 1995 | 798 | 0.020 |
Why?
|
| Pubic Bone | 1 | 1989 | 29 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2014 | 616 | 0.020 |
Why?
|
| Tretinoin | 1 | 2012 | 517 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1990 | 238 | 0.020 |
Why?
|
| Electromyography | 1 | 1995 | 1379 | 0.020 |
Why?
|
| Estrone | 1 | 1990 | 240 | 0.020 |
Why?
|
| Graft Survival | 1 | 2000 | 3737 | 0.020 |
Why?
|
| Leiomyoma | 1 | 1995 | 730 | 0.020 |
Why?
|
| Warfarin | 1 | 1998 | 1496 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2015 | 986 | 0.020 |
Why?
|
| Light | 1 | 1976 | 1374 | 0.020 |
Why?
|
| Internet | 1 | 2002 | 3064 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 12745 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1990 | 682 | 0.020 |
Why?
|
| Endoscopy | 1 | 1999 | 1785 | 0.020 |
Why?
|
| Pregnadienediols | 1 | 1988 | 9 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2015 | 803 | 0.020 |
Why?
|
| Lipase | 3 | 1978 | 314 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2012 | 4245 | 0.020 |
Why?
|
| Fractures, Closed | 1 | 1989 | 88 | 0.020 |
Why?
|
| Fluocinolone Acetonide | 1 | 1988 | 36 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1998 | 9146 | 0.020 |
Why?
|
| Health Care Reform | 1 | 2018 | 1261 | 0.020 |
Why?
|
| Macaca | 1 | 1990 | 440 | 0.020 |
Why?
|
| Bone Density | 1 | 2002 | 3468 | 0.020 |
Why?
|
| Survival Analysis | 4 | 2012 | 10252 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2003 | 8863 | 0.020 |
Why?
|
| Emergencies | 2 | 1985 | 1170 | 0.020 |
Why?
|
| Neck | 1 | 2013 | 697 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 1998 | 2645 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1976 | 1180 | 0.020 |
Why?
|
| Triamcinolone Acetonide | 1 | 1988 | 101 | 0.020 |
Why?
|
| Scoliosis | 2 | 1992 | 725 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1990 | 365 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 1974 | 563 | 0.020 |
Why?
|
| Metacarpus | 1 | 1987 | 35 | 0.020 |
Why?
|
| Contracture | 1 | 1990 | 223 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1425 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2010 | 398 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1976 | 1889 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4149 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2001 | 7785 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2012 | 648 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2000 | 4397 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 1990 | 427 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1995 | 1738 | 0.020 |
Why?
|
| Brain Edema | 1 | 1972 | 617 | 0.020 |
Why?
|
| Muscle Spasticity | 1 | 1988 | 154 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 8301 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2005 | 3479 | 0.020 |
Why?
|
| Endothelium | 1 | 1990 | 778 | 0.020 |
Why?
|
| Surgical Flaps | 2 | 1988 | 1640 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 2009 | 353 | 0.020 |
Why?
|
| Diagnosis, Differential | 4 | 1997 | 12959 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2012 | 40561 | 0.020 |
Why?
|
| Prospective Studies | 8 | 2014 | 53288 | 0.020 |
Why?
|
| Rhode Island | 1 | 1987 | 347 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 850 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1995 | 1400 | 0.020 |
Why?
|
| Cell Transplantation | 2 | 2000 | 477 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2297 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1990 | 1801 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3386 | 0.020 |
Why?
|
| Private Practice | 1 | 2007 | 154 | 0.020 |
Why?
|
| Bone Transplantation | 2 | 1983 | 907 | 0.020 |
Why?
|
| Emotions | 1 | 1998 | 2661 | 0.020 |
Why?
|
| Electric Stimulation Therapy | 1 | 1992 | 605 | 0.020 |
Why?
|
| Cost Savings | 1 | 2011 | 926 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 3002 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2902 | 0.020 |
Why?
|
| North America | 1 | 2009 | 1249 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
| Tetracycline | 2 | 1998 | 214 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 1017 | 0.020 |
Why?
|
| Wounds, Stab | 1 | 1985 | 71 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1978 | 402 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2539 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 6993 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2009 | 924 | 0.020 |
Why?
|
| Pubic Symphysis | 2 | 1989 | 21 | 0.020 |
Why?
|
| Military Personnel | 1 | 1974 | 1133 | 0.020 |
Why?
|
| Child | 11 | 2006 | 77709 | 0.020 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2005 | 79 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 1986 | 230 | 0.020 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2005 | 83 | 0.020 |
Why?
|
| Atlanto-Axial Joint | 1 | 1984 | 61 | 0.020 |
Why?
|
| Bupivacaine | 1 | 1988 | 411 | 0.020 |
Why?
|
| Polyethylene | 1 | 2005 | 184 | 0.010 |
Why?
|
| Depression | 2 | 2014 | 7766 | 0.010 |
Why?
|
| Ointments | 2 | 1997 | 59 | 0.010 |
Why?
|
| Risk | 2 | 2012 | 9687 | 0.010 |
Why?
|
| Ethynodiol Diacetate | 1 | 1983 | 5 | 0.010 |
Why?
|
| Disease-Free Survival | 3 | 2003 | 6895 | 0.010 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 1983 | 22 | 0.010 |
Why?
|
| Hydroxyprogesterones | 1 | 1983 | 25 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1970 | 760 | 0.010 |
Why?
|
| Growth Plate | 1 | 1985 | 274 | 0.010 |
Why?
|
| Osteolysis | 1 | 2005 | 270 | 0.010 |
Why?
|
| Fibula | 1 | 1985 | 269 | 0.010 |
Why?
|
| Androstenedione | 1 | 1983 | 131 | 0.010 |
Why?
|
| Nails | 1 | 1985 | 292 | 0.010 |
Why?
|
| Nerve Tissue | 1 | 1983 | 79 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1999 | 7913 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1998 | 4599 | 0.010 |
Why?
|
| Polyethylenes | 1 | 2005 | 285 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1983 | 116 | 0.010 |
Why?
|
| Elbow | 1 | 1983 | 138 | 0.010 |
Why?
|
| North Carolina | 1 | 2003 | 315 | 0.010 |
Why?
|
| Disabled Persons | 1 | 2012 | 1212 | 0.010 |
Why?
|
| Busulfan | 1 | 2003 | 263 | 0.010 |
Why?
|
| Hydrocortisone | 2 | 1997 | 1826 | 0.010 |
Why?
|
| Artificial Limbs | 2 | 1974 | 123 | 0.010 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1983 | 113 | 0.010 |
Why?
|
| Vietnam | 2 | 1973 | 408 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1988 | 545 | 0.010 |
Why?
|
| Neurologic Manifestations | 2 | 1972 | 20 | 0.010 |
Why?
|
| Replantation | 1 | 1983 | 148 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2011 | 2268 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 13695 | 0.010 |
Why?
|
| Multigene Family | 1 | 2005 | 1102 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 24260 | 0.010 |
Why?
|
| Spinal Fusion | 3 | 2005 | 1241 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1969 | 1809 | 0.010 |
Why?
|
| Melphalan | 1 | 2003 | 431 | 0.010 |
Why?
|
| Glucocorticoids | 4 | 1988 | 2107 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1988 | 1504 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1983 | 744 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1996 | 3481 | 0.010 |
Why?
|
| Cognition | 1 | 1998 | 6770 | 0.010 |
Why?
|
| Psoriasis | 1 | 1988 | 898 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2148 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1983 | 548 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1983 | 869 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2005 | 23403 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 1996 | 1770 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 19905 | 0.010 |
Why?
|
| Halothane | 1 | 1980 | 206 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1980 | 134 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2005 | 1539 | 0.010 |
Why?
|
| Wrestling | 1 | 1979 | 18 | 0.010 |
Why?
|
| Femoral Neck Fractures | 2 | 1989 | 138 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9849 | 0.010 |
Why?
|
| Compressive Strength | 1 | 1999 | 169 | 0.010 |
Why?
|
| Dermatoglyphics | 1 | 1978 | 21 | 0.010 |
Why?
|
| Ectromelia | 1 | 1978 | 31 | 0.010 |
Why?
|
| Trail Making Test | 1 | 1998 | 57 | 0.010 |
Why?
|
| Triglycerides | 2 | 1978 | 2454 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2715 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 3282 | 0.010 |
Why?
|
| Skin Manifestations | 1 | 1977 | 17 | 0.010 |
Why?
|
| Cysts | 1 | 1983 | 678 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 3002 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1988 | 2278 | 0.010 |
Why?
|
| Urinary Bladder Diseases | 1 | 1978 | 166 | 0.010 |
Why?
|
| Mucopolysaccharidosis II | 1 | 1977 | 27 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 1999 | 323 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 2065 | 0.010 |
Why?
|
| Etoposide | 1 | 1998 | 641 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1980 | 865 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7729 | 0.010 |
Why?
|
| Methylprednisolone | 2 | 1975 | 387 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3920 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1984 | 880 | 0.010 |
Why?
|
| Pellagra | 1 | 1976 | 9 | 0.010 |
Why?
|
| Adrenal Gland Diseases | 1 | 1997 | 138 | 0.010 |
Why?
|
| Porphyrias | 1 | 1976 | 57 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 1996 | 173 | 0.010 |
Why?
|
| Hip Dislocation, Congenital | 1 | 1978 | 225 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
| Chromium Alloys | 1 | 1995 | 77 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1983 | 1951 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2003 | 41006 | 0.010 |
Why?
|
| Gelatinases | 1 | 1995 | 94 | 0.010 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1976 | 49 | 0.010 |
Why?
|
| Monocytes | 1 | 2005 | 2596 | 0.010 |
Why?
|
| Cranial Irradiation | 1 | 1998 | 401 | 0.010 |
Why?
|
| Mitomycin | 1 | 1996 | 259 | 0.010 |
Why?
|
| Collagenases | 1 | 1995 | 228 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1980 | 1726 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1997 | 648 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1997 | 357 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1996 | 4933 | 0.010 |
Why?
|
| Arthritis, Experimental | 1 | 1997 | 291 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1997 | 595 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1997 | 546 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1983 | 1065 | 0.010 |
Why?
|
| Enzymes | 1 | 1976 | 266 | 0.010 |
Why?
|
| Phospholipids | 1 | 1978 | 784 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1983 | 1475 | 0.010 |
Why?
|
| Neomycin | 1 | 1973 | 88 | 0.010 |
Why?
|
| Textiles | 1 | 1973 | 46 | 0.010 |
Why?
|
| Granulation Tissue | 1 | 1973 | 93 | 0.010 |
Why?
|
| Dermatitis | 1 | 1976 | 197 | 0.010 |
Why?
|
| Dextrans | 1 | 1975 | 595 | 0.010 |
Why?
|
| Traction | 1 | 1973 | 106 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1974 | 447 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 1974 | 101 | 0.010 |
Why?
|
| Skin Neoplasms | 2 | 1988 | 5686 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1974 | 212 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 3251 | 0.010 |
Why?
|
| Nucleic Acids | 1 | 1976 | 182 | 0.010 |
Why?
|
| Angiography | 1 | 1979 | 1639 | 0.010 |
Why?
|
| Plastics | 1 | 1973 | 123 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5751 | 0.010 |
Why?
|
| Amputees | 1 | 1973 | 75 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1976 | 675 | 0.010 |
Why?
|
| Ethionamide | 1 | 1972 | 11 | 0.010 |
Why?
|
| Decompression Sickness | 1 | 1972 | 12 | 0.010 |
Why?
|
| Kanamycin | 1 | 1972 | 64 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1997 | 1099 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1976 | 297 | 0.010 |
Why?
|
| Foot Diseases | 1 | 1974 | 143 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1996 | 624 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1974 | 454 | 0.010 |
Why?
|
| Transducers | 1 | 1974 | 252 | 0.010 |
Why?
|
| Testosterone | 1 | 1983 | 2420 | 0.010 |
Why?
|
| Scapula | 2 | 1988 | 164 | 0.010 |
Why?
|
| Epiphyses, Slipped | 1 | 1972 | 87 | 0.010 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1972 | 60 | 0.010 |
Why?
|
| Inflammation | 2 | 2005 | 10638 | 0.010 |
Why?
|
| Tuberculin Test | 1 | 1972 | 214 | 0.010 |
Why?
|
| Brachial Artery | 1 | 1973 | 369 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1641 | 0.010 |
Why?
|
| Gaucher Disease | 1 | 1972 | 112 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1997 | 2716 | 0.010 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1976 | 547 | 0.010 |
Why?
|
| Motion | 1 | 1995 | 798 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1976 | 2104 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1998 | 2234 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1995 | 723 | 0.010 |
Why?
|
| Surgical Mesh | 1 | 1973 | 276 | 0.010 |
Why?
|
| Myelography | 1 | 1970 | 69 | 0.010 |
Why?
|
| Isoniazid | 1 | 1972 | 274 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1971 | 383 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1972 | 337 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13033 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1996 | 2879 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1972 | 862 | 0.010 |
Why?
|
| Groin | 1 | 1989 | 104 | 0.010 |
Why?
|
| Remission Induction | 1 | 1995 | 2386 | 0.010 |
Why?
|
| Popliteal Vein | 1 | 1989 | 43 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1969 | 554 | 0.010 |
Why?
|
| Hip Dislocation | 1 | 1972 | 244 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1973 | 845 | 0.010 |
Why?
|
| Tachycardia | 1 | 1971 | 619 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1969 | 467 | 0.010 |
Why?
|
| Cholesterol | 1 | 1978 | 2917 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1999 | 9239 | 0.010 |
Why?
|
| Anesthesia | 1 | 1980 | 1561 | 0.010 |
Why?
|
| Infant | 2 | 2003 | 35136 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.000 |
Why?
|
| Necrosis | 1 | 1972 | 1643 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7799 | 0.000 |
Why?
|
| Chordoma | 1 | 1970 | 359 | 0.000 |
Why?
|
| Drainage | 1 | 1972 | 1142 | 0.000 |
Why?
|
| Research Design | 1 | 2002 | 5987 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1997 | 4026 | 0.000 |
Why?
|
| DNA Repair | 1 | 1976 | 2046 | 0.000 |
Why?
|
| Clavicle | 1 | 1988 | 209 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1972 | 1092 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1989 | 1423 | 0.000 |
Why?
|
| Homozygote | 1 | 1969 | 1785 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1971 | 1265 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12245 | 0.000 |
Why?
|
| Algorithms | 1 | 2005 | 13881 | 0.000 |
Why?
|
| Steroids | 1 | 1970 | 930 | 0.000 |
Why?
|
| Oxygen | 1 | 1976 | 4189 | 0.000 |
Why?
|
| Anemia, Sickle Cell | 1 | 1972 | 1018 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1969 | 2187 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2429 | 0.000 |
Why?
|
| Fever | 1 | 1971 | 1616 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1972 | 1161 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1988 | 1677 | 0.000 |
Why?
|
| Models, Biological | 1 | 1999 | 9583 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 1976 | 2376 | 0.000 |
Why?
|
| Heterozygote | 1 | 1969 | 2804 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1971 | 1199 | 0.000 |
Why?
|
| Neoplasms | 1 | 2012 | 21683 | 0.000 |
Why?
|
| Alcoholism | 1 | 1972 | 1906 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1996 | 12354 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1992 | 2684 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1971 | 6442 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1998 | 7181 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1996 | 9959 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1971 | 3461 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1974 | 8554 | 0.000 |
Why?
|
| Hernia | 1 | 1978 | 71 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1972 | 2861 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1972 | 4251 | 0.000 |
Why?
|
| Hematuria | 1 | 1978 | 235 | 0.000 |
Why?
|
| Thigh | 1 | 1977 | 247 | 0.000 |
Why?
|
| Intestinal Obstruction | 1 | 1978 | 424 | 0.000 |
Why?
|
| Succinates | 1 | 1971 | 83 | 0.000 |
Why?
|
| Pregnancy | 1 | 1972 | 29144 | 0.000 |
Why?
|
| Digitalis Glycosides | 1 | 1970 | 47 | 0.000 |
Why?
|
| Aminophylline | 1 | 1970 | 40 | 0.000 |
Why?
|
| Mice | 1 | 1997 | 81183 | 0.000 |
Why?
|
| Cortisone | 1 | 1970 | 89 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1971 | 1420 | 0.000 |
Why?
|
| Diuretics | 1 | 1970 | 592 | 0.000 |
Why?
|
| Sodium | 1 | 1971 | 1623 | 0.000 |
Why?
|
| Positive-Pressure Respiration | 1 | 1970 | 633 | 0.000 |
Why?
|
| Morphine | 1 | 1970 | 657 | 0.000 |
Why?
|